Skip to Content

NVR ZY1 (Zykadia 150 mg)

Generic Name: ceritinib

Pill with imprint NVR ZY1 is Blue, Round and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Zykadia is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR ZY1

Zykadia

Generic Name
ceritinib
Imprint
NVR ZY1
Strength
150 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0694

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.